September 23, 2010 – We present here a very significant announcement by the American Food and Drug Administration (FDA) in its original. Please note that the European Medicines Agency (EMEA) also today recommended the suspension of the marketing authorisations for …

FDA Significantly Restricts Access to the Diabetes Drug Rosiglitazone [Avandia] Read more »